Your browser is no longer supported. Please, upgrade your browser.
Settings
ADHD Alcobra Ltd. daily Stock Chart
ADHD [NASD]
Alcobra Ltd.
Index- P/E- EPS (ttm)-0.83 Insider Own30.00% Shs Outstand27.27M Perf Week12.97%
Market Cap56.99M Forward P/E- EPS next Y-0.95 Insider Trans0.00% Shs Float23.56M Perf Month9.42%
Income-19.40M PEG- EPS next Q-0.28 Inst Own66.40% Short Float5.63% Perf Quarter-56.64%
Sales- P/S- EPS this Y62.60% Inst Trans-13.81% Short Ratio3.18 Perf Half Y-59.02%
Book/sh2.36 P/B0.89 EPS next Y-1.10% ROA-35.50% Target Price5.17 Perf Year-64.70%
Cash/sh1.82 P/C1.15 EPS next 5Y- ROE-37.20% 52W Range1.77 - 6.50 Perf YTD-66.72%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-67.85% Beta1.41
Dividend %- Quick Ratio26.00 Sales past 5Y- Gross Margin- 52W Low18.08% ATR0.13
Employees19 Current Ratio26.00 Sales Q/Q- Oper. Margin- RSI (14)56.50 Volatility6.48% 7.99%
OptionableYes Debt/Eq0.00 EPS Q/Q25.40% Profit Margin- Rel Volume2.19 Prev Close1.92
ShortableYes LT Debt/Eq0.00 EarningsNov 17 BMO Payout- Avg Volume416.78K Price2.09
Recom2.80 SMA207.87% SMA50-4.68% SMA200-47.15% Volume913,071 Change8.85%
Nov-02-16Upgrade WBB Securities Sell → Hold $4 → $1.90
Sep-30-16Downgrade Piper Jaffray Overweight → Neutral
Sep-29-16Downgrade Cantor Fitzgerald Buy → Hold
Sep-12-16Downgrade WBB Securities Hold → Sell $5 → $4
Aug-01-16Initiated Barclays Equal Weight $8
Jun-21-16Resumed ROTH Capital Buy
Jun-07-16Initiated Cantor Fitzgerald Buy $16
Feb-18-16Initiated Jefferies Buy
Jan-25-16Initiated Oppenheimer Outperform $16
Aug-14-15Reiterated ROTH Capital Buy $10 → $16
Jun-24-15Downgrade WBB Securities Speculative Buy → Hold $5
Nov-18-14Reiterated ROTH Capital Buy $30 → $10
Oct-23-14Downgrade FBR Capital Outperform → Mkt Perform $22 → $4
Oct-07-14Upgrade WBB Securities Hold → Speculative Buy $18 → $9
Oct-07-14Upgrade FBR Capital Mkt Perform → Outperform $23 → $22
Oct-06-14Reiterated ROTH Capital Buy $40 → $30
Aug-27-14Initiated FBR Capital Mkt Perform $23
Jun-26-14Initiated WBB Securities Hold $18
Apr-17-14Initiated Canaccord Genuity Buy $24
Dec-04-13Initiated Stifel Buy $27
Dec-06-16 10:12AM  Alcobra Ltd. :ADHD-US: Earnings Analysis: Q3, 2016 By the Numbers : December 6, 2016
Nov-15-16 12:14PM  Edited Transcript of ADHD earnings conference call or presentation 15-Nov-16 1:30pm GMT -5.13%
07:40AM  Alcobra reports 3Q loss
07:30AM  Alcobra Announces Third Quarter 2016 Financial Results and Provides Corporate Update GlobeNewswire
07:07AM  Q3 2016 Alcobra Ltd Earnings Release - Before Market Open
06:55AM  Corbus Pharma Bear Thesis Is Alive and Well on Sclerosis Drug Data Skewed Positive
Nov-07-16 08:00AM  Alcobra Ltd. to Participate in Upcoming Healthcare Conferences GlobeNewswire
Nov-02-16 09:27AM  Alcobra Pharma upgraded by WBB Securities
Nov-01-16 08:32AM  Jazz Pharma (JAZZ) Q3 Earnings: A Disappointment in Store?
08:00AM  Alcobra Ltd. to Release Third Quarter Financial Results and Host Corporate Update Conference Call & Webcast on November 15 GlobeNewswire
Oct-23-16 06:19PM  RA Capital Management Slashes Alcobra Ltd (ADHD) Position After FDA Clinical Hold at Insider Monkey
Oct-07-16 08:48AM  Update from Alcobra on Recent FDA Communications GlobeNewswire
Oct-02-16 10:10AM  5 Companies That Destroyed Shareholders Last Week at 24/7 Wall St.
Sep-30-16 01:39PM  [video]Alcobra (ADHD) Stock Sliding, Downgraded After FDA Clinical Hold
Sep-29-16 12:46PM  Heres Why These Five Stocks Are in the Spotlight Today at Insider Monkey -45.67%
12:05PM  Alcobra Tumbles on FDA Clinical Hold
10:12AM  Alcobra (ADHD) Stock Tumbles on FDA Clinical Hold, Cantor Remains Bullish
Sep-28-16 08:01PM  Alcobra Announces IND Clinical Hold Affecting the MDX Phase III MEASURE Study GlobeNewswire
Aug-30-16 02:36PM  Edited Transcript of ADHD earnings conference call or presentation 30-Aug-16 12:30pm GMT
07:11AM  Alcobra reports 2Q loss
07:07AM  Q2 2016 Alcobra Ltd Earnings Release - Before Market Open
07:00AM  Alcobra Announces Second Quarter 2016 Financial Results and Provides Corporate Update GlobeNewswire
Aug-15-16 08:00AM  Alcobra Ltd. to Release Second Quarter Financial Results and Host Corporate Update Conference Call & Webcast on Tuesday, August 30 GlobeNewswire
Aug-09-16 08:36AM  Is a Surprise Coming for Alcobra (ADHD) This Earnings Season? +5.89%
Aug-04-16 08:25AM  Alcobra (ADHD) Looks Good: Stock Adds 14.4% in Session
Jul-19-16 08:00AM  Alcobra Granted European Orphan Drug Designation for Metadoxine in Fragile X Syndrome GlobeNewswire
Jul-05-16 08:00AM  Alcobra Ltd. to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference GlobeNewswire
Jun-06-16 02:31PM  Alcobra Ltd. :ADHD-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016
Jun-01-16 08:00AM  Alcobra Ltd. to Participate in Upcoming Investment Conferences GlobeNewswire
May-20-16 08:30AM  Alcobra (ADHD) Catches Eye: Stock Adds 6.3% in Session
06:08AM  7 Stocks Under $10 Making Big Moves Higher
May-16-16 10:49AM  Edited Transcript of ADHD earnings conference call or presentation 16-May-16 12:30pm GMT
09:30AM  The Zacks Analyst Blog Highlights: Alcobra, Editas Medicine, Syndax Pharmaceuticals, Seres Therapeutics and Neos Therapeutics
08:15AM  Alcobra reports 1Q loss
08:00AM  Alcobra Announces First Quarter 2016 Financial Results and Provides Corporate Update GlobeNewswire
07:07AM  Q1 2016 Alcobra Ltd Earnings Release - Before Market Open
May-13-16 09:26AM  Drug Stocks' Earnings to Watch on May 16: ADHD, MCRB & More +9.81%
May-08-16 09:17AM  (ADHD) Who are Alcobra's Main Competitors? at Investopedia
May-04-16 08:00AM  Alcobra Ltd. to Release First Quarter Financial Results and Host Corporate Update Conference Call & Webcast on May 16 GlobeNewswire -7.88%
Apr-07-16 08:40AM  Recro Pharma (REPH) Looks Good: Stock Adds 5% in Session
Apr-04-16 08:40AM  What Falling Estimates & Price Mean for Lannett (LCI) +7.12%
Apr-01-16 06:34AM  Alcobra (ADHD) Sees Hammer Chart Pattern: Time to Buy?
Mar-31-16 10:10AM  Grab These 4 Incredible Momentum Stocks for Less Than $10
Mar-30-16 08:00AM  Ohr Pharmaceutical (OHRP) Worth Watching: Stock Up 16.5%
Mar-28-16 08:00AM  Synergy Pharmaceuticals (SGYP) Jumps: Stock Gains 6.1%
Mar-10-16 01:04PM  ALCOBRA LTD. Financials
Mar-01-16 08:00AM  Alcobra Ltd. to Present at Upcoming Investment Conferences GlobeNewswire
Feb-19-16 09:30AM  New Strong Buy Stocks for February 19th
08:15AM  ArQule (ARQL) Shows Strength: Stock Adds 7.6% in Session
Feb-18-16 08:37AM  How Alcobra (ADHD) Stock Stands Out in a Strong Industry
Feb-17-16 04:49PM  Edited Transcript of ADHD earnings conference call or presentation 17-Feb-16 1:30pm GMT -5.30%
08:48AM  CORRECTING and REPLACING -- Alcobra Announces Fourth Quarter and Fiscal 2015 Financial Results and Provides Corporate Update GlobeNewswire
08:15AM  Alcobra reports 4Q loss
08:00AM  Alcobra Announces Fourth Quarter and Fiscal 2015 Financial Results and Provides Corporate Update GlobeNewswire
07:07AM  Q4 2015 Alcobra Ltd Earnings Release - Time Not Supplied
Feb-16-16 11:54AM  Can The Uptrend Continue for Alcobra (ADHD)?
Feb-15-16 08:30AM  Should You Buy Alcobra (ADHD) Ahead of Earnings?
Feb-11-16 10:45AM  Lockup Expiry For FitBit, Alcobra
Feb-08-16 03:00PM  Will CVS Health (CVS) Outshine Earnings Expectations in Q4?
02:50PM  Will Henry Schein (HSIC) Surprise Q4 Earnings Estimates?
Feb-02-16 08:00AM  Alcobra Ltd. to Release Fourth Quarter and Fiscal Year 2015 Financial Results and Host Corporate Update Conference Call & Webcast on February 17 GlobeNewswire
Feb-01-16 01:50PM  Is Illumina (ILMN) Poised to Beat Earnings Estimates in Q4?
Jan-29-16 01:31PM  Edwards Lifesciences (EW) Likely to Top Earnings Again in Q4
Jan-28-16 08:42AM  Alcobra Ltd. to Present at Upcoming Investment Conferences at noodls
08:00AM  Alcobra Ltd. to Present at Upcoming Investment Conferences GlobeNewswire
Dec-17-15 08:00AM  Alcobra Added to the NASDAQ Biotechnology Index GlobeNewswire
Dec-01-15 08:44AM  Why Alcobra (ADHD) Stock Might be a Great Pick
Nov-28-15 08:47AM  Layne Christensen Company (LAYN): Are Hedge Funds Right About This Stock? at Insider Monkey
Nov-24-15 08:00AM  Alcobra Ltd. to Participate in Piper Jaffray 27th Annual Healthcare Conference GlobeNewswire +6.40%
Nov-23-15 08:56AM  Why the Earnings Streak Will Continue for Alcobra (ADHD)
07:45AM  Beyond the Chart, What Price Data Reveals - Research on Alcobra, Control4, Contango Oil & Gas, and Cellceutix Accesswire
Nov-20-15 12:27PM  Two Activist Plays And Two Biotech Moves You Should Check Out at Insider Monkey
Nov-17-15 04:06PM  Edited Transcript of ADHD earnings conference call or presentation 17-Nov-15 1:30pm GMT
07:07AM  Q3 2015 Alcobra Ltd Earnings Release - Before Market Open
Nov-16-15 08:00AM  Alcobra Ltd. to Present at Upcoming Investment Conferences Company Will Host Corporate Update Conference Call & Webcast on November 17 GlobeNewswire
Nov-13-15 05:21PM  8 Stocks Moving In Friday's After-Hours Session -12.22%
11:20AM  Alcobra Gears Up for Secondary Offering
08:45AM  Alcobra Ltd. Prices Public Offering of Ordinary Shares GlobeNewswire
Nov-12-15 04:37PM  Alcobra reports 3Q loss -5.19%
04:05PM  Alcobra Ltd. Announces Proposed Public Offering of Ordinary Shares GlobeNewswire
04:01PM  Alcobra Announces Third Quarter 2015 Financial Results and Provides Corporate Update GlobeNewswire
Nov-05-15 08:00AM  Alcobra Ltd. to Release Third Quarter 2015 Financial Results and Host Corporate Update Conference Call & Webcast on November 17 GlobeNewswire
Oct-29-15 02:10PM  McKesson (MCK) Beats on Earnings in Q2, Upgrades View +5.32%
Oct-28-15 08:03AM  Can the Uptrend Continue for Alcobra (ADHD)? +5.92%
Oct-22-15 04:35PM  Shire (SHPG) Gets CRL for Dry Eye Disease Drug from FDA
Oct-20-15 04:25PM  Supernus Inks Trokendi XR Settlement Agreement with Endo
Oct-09-15 08:15AM  Galmed Pharmaceuticals (GLMD) Jumps: Stock Rises 13.7%
Oct-08-15 02:45PM  UCB Reveals Positive Data on Vimpat Monotherapy Study -7.11%
Sep-25-15 08:30AM  Loxo Oncology (LOXO) in Focus: Stock Up 9.1% in Session -7.07%
Sep-24-15 08:51AM  Concert Pharmaceuticals (CNCE) Jumps: Stock Rises 23.1%
Sep-22-15 09:45AM  Infinity Pharmaceuticals (INFI) Jumps: Stock Moves Up 8.6% -5.28%
Sep-21-15 08:00AM  FDA Grants Fast Track Designation to Alcobra's MDX for Fragile X Syndrome GlobeNewswire
Sep-18-15 09:30AM  New Strong Buy Stocks for September 18th +5.90%
Sep-15-15 09:30AM  New Strong Buy Stocks for September 15th
09:18AM  Juniper Pharmaceuticals (JNP) in Focus: Stock Jumps 5.3%
Sep-10-15 08:54AM  How Alcobra Ltd. (ADHD) Stock Stands Out in a Strong Industry
08:30AM  Heron Therapeutics (HRTX) in Focus: Stock Rises 10.2% (Revised)
Sep-09-15 04:10PM  Pacira Files Lawsuit vs. FDA Over Exparel Marketing
09:21AM  Heron Therapeutics (HRTX) in Focus: Stock Rises 10.2%
08:37AM  What Falling Estimates & Price Mean for Merus Labs International (MSLI)
Alcobra Ltd., a biopharmaceutical company, focuses on the development and commercialization of oral drug candidates. The company is primarily developing MDX (metadoxine), an onset/extended release formulation of the chemical pyridoxine pyroglutamate, which is in Phase III clinical trial for adults with attention deficit hyperactivity disorder (ADHD); in Phase II clinical trial for pediatric with ADHD; and which is completed Phase II clinical trial in adolescents and adults with Fragile X Syndrome. Alcobra Ltd. was founded in 2008 and is headquartered in Tel Aviv, Israel.